Pain Management Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Growth Factors of Pain Management Devices Market

The pain management devices market size was valued at USD 3922.9 million in 2018, and the market is now projected tgrow USD 14123.9 million in 2032 exhibiting a CAGR of 9.6% during the forecast period of 2019-2032.

The COVID-19 pandemic had a substantial impact at the pain management devices market, as healthcare centers confronted disruptions and prioritization of COVID-related treatments. Non-critical procedures, including pain management treatments, had been behind schedule, or canceled, resulting in a temporary decline in demand for pain management devices. However, the upward push in chronic pain cases and the developing want for remote care all through the pandemic multiplied the adoption of domestic-primarily based and wearable pain control devices. Additionally, healthcare systems are more and more focusing on non-opioid pain management answers, riding lengthy-term growth in the market. The market is predicted tget better as healthcare offerings return tregular operations and telehealth turns intgreater incorporated intpain control strategies.

Neuromodulation devices were a significant segment in 2018 within the global pain management devices market, and its use is expected tbe a reason behind market enhancement from 2018 t2026. Such equipment that elicits apprehensive system through electrical impulses are spinal cord stimulation, deep brain stimulation, and dorsal root ganglion stimulation. It is mainly important in treatment of diseases such as Parkinson’s ailment, vital tremor, and dystonia. The growth of chronic pain and neurological illnesses and higher awareness of neuromodulation devices alssupport the market. Slong as these remedies are in high demand, those devices are certain tmaintain their appeal.

The latest developments in the pain management devices market consist of the growing adoption of wearable and transportable devices for at-home pain control, providing patients with extra flexibility and luxury. Neuromodulation technology, together with spinal twine and deep brain stimulation, are gaining traction for his or her effectiveness in treating chronic pain and neurological problems. The integration of artificial intelligence and advanced algorithms in pain control devices is enhancing remedy precision and affected person effects. Additionally, there is an increasing focus on non-invasive and drug-free pain control answers. The rise in continual pain conditions and the shift toward personalized healthcare are in addition riding market increase.

Comprehensive Analysis of Pain Management Devices Market

The pain management devices market growth is alsincreasing exponentially because of the segmentation of its market. This market expansion rightly provides a thorough market breakdown near tthe industry considering the leading supply and demand forces. These segmentations are methodically segregated by product type, by application, by end user, and by geography. By product type incudes electrical stimulation devices, RF ablation devices, neuromodulation devices and infusion pumps. By application incudes musculoskeletal, brain, cancer, neuropathy, and others. By end user incudes physiotherapy centers, hospitals and clinics and others. By geography incudes North America, Europe, Asia Pacific, and rest of the world.

The North America region lead the pain management devices market share by benefitting a market size of USD 3032.0 million in 2018 due tits increasing adoption of technologically advanced devices.

Top players in the market have their responsibility of healthcare industrial prospectus growth of the retailing industry and the markets. These players include, Medtronic, Boston Scientific Corporation, LivaNova, Abbott, DJO Global LLC, SPR Therapeutics, and NevrCorp these market players provide a level-playing competitive landscape.

In May 2021, NeuraLace Medical, Inc. announced the enrolment of its first patient in the AXON-RCT U.S. trial, testing Axon Therapy, a treatment for chronic nerve pain using focused magnetic pulses tactivate damaged peripheral nerve axons.

Segmentation Table

SEGMENTATION DETAILS

By Product Type

Electrical Stimulation Devices

TENS (Transcutaneous Electric Nerve Stimulation)

EMS (Electric Muscle Stimulation)

Others

RF Ablation Devices

Neuromodulation Devices

Spinal Cord Stimulation

Deep Brain Stimulation

Others

Infusion Pumps

By Application

Musculoskeletal

Brain

Cancer

Neuropathy

Others

By End User

Physiotherapy Centers

Hospitals and Clinics

Others

By Geography

North America (USA and Canada)

Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

Rest of the World